Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
Caroline Nørgaard-PedersenKaspar NielsenRudi SteffensenLine EriksenMalene Møller JørgensenUlrik Schiøler KesmodelOle Bjarne ChristiansenPublished in: BMJ open (2022)
NCT04701034.